Thrombectomy Devices in Coronary Intervention

Aaron Horne Jr; Matthews Chacko

doi:10.1016/j.iccl.2012.12.001

Thrombectomy Devices in Coronary Intervention

Interv Cardiol Clin. 2013 Apr;2(2):347-359. doi: 10.1016/j.iccl.2012.12.001. Epub 2013 Mar 27.

Authors

Aaron Horne Jr¹, Matthews Chacko²

Affiliations

¹ Division of Cardiology, Johns Hopkins Hospital, Johns Hopkins University, 1800 Orleans Street, Baltimore, MD 21287, USA.
² Division of Cardiology, Johns Hopkins Hospital, Johns Hopkins University, 1800 Orleans Street, Baltimore, MD 21287, USA. Electronic address: mchacko@jhmi.edu.

PMID: 28582141
DOI: 10.1016/j.iccl.2012.12.001

Abstract

Primary percutaneous coronary intervention is the favored mode of reperfusion therapy for ST-elevation myocardial infarction (STEMI) when able to be performed in a timely fashion in appropriately selected patients. However, controversy about the role of coronary thrombectomy in the management of STEMI persists because of a paucity of favorable historical data. After the TAPAS trial thrombectomy has gained favor in recent years. The results of the TOTAL, TASTE, and SMART percutaneous coronary intervention trials will provide further insight into the use of thrombectomy in STEMI. This article examines the relevant trial evidence regarding how to best manage and apply thrombectomy in clinical practice.

Keywords: Percutaneous coronary intervention; Rheolysis; ST-elevation myocardial infarction; Thrombectomy.

Publication types

Review